SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-24-000938
Filing Date
2024-05-09
Accepted
2024-05-08 18:10:17
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tlcc-20240331.htm   iXBRL 10-Q 1264557
7 EXHIBIT 31.1 ex311_1.htm EX-31.1 13037
8 EXHIBIT 32.1 ex321_2.htm EX-32.1 7196
  Complete submission text file 0001753926-24-000938.txt   7559606

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20240331_def.xml EX-101.DEF 298116
3 PRESENTATION tlcc-20240331_pre.xml EX-101.PRE 458476
4 CALCULATION tlcc-20240331_cal.xml EX-101.CAL 94457
5 LABEL tlcc-20240331_lab.xml EX-101.LAB 764685
6 SCHEMA tlcc-20240331.xsd EX-101.SCH 54590
69 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20240331_htm.xml XML 1277028
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 24927839
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)